Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mannello

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The Pharmacogenomics Journal|July 29, 2009
Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approachesF Mannello
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2001
Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implicationsF Mannello, G Gazzanelli
British Journal of Cancer|August 17, 2016
Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?D Ligi, F Mannello
Cancer Detection and Prevention|January 1, 1992
Improved "electrophoretic map" of breast cyst fluid proteinsR Troccoli, F Mannello
Breast Cancer Research : BCR|July 4, 2001
Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?F Mannello, G Gazzanelli
Lancet (London, England)|May 31, 2001
Prostate cancer screeningF Mannello, G Gazzanelli
International Angiology : a Journal of the International Union of Angiology|April 24, 2014
Pathophysiology of chronic venous diseaseJ D Raffetto, F Mannello
Lancet (London, England)|August 31, 1999
Breast cancer in women with palpable breast cystsF Mannello, M Malatesta, G Gazzanelli
Cancer|July 1, 1995
Breast cancer diagnosis by lactate dehydrogenase isozymes in nipple dischargeF Mannello, F Marcheggiani, G Gazzanelli
Current Cancer Drug Targets|June 25, 2005
Matrix metalloproteinase inhibitors as anticancer therapeuticsF Mannello, G Tonti, S Papa
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The Pharmacogenomics Journal|July 29, 2009
Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approachesF Mannello
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2001
Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implicationsF Mannello, G Gazzanelli
British Journal of Cancer|August 17, 2016
Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?D Ligi, F Mannello
Cancer Detection and Prevention|January 1, 1992
Improved "electrophoretic map" of breast cyst fluid proteinsR Troccoli, F Mannello
Breast Cancer Research : BCR|July 4, 2001
Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?F Mannello, G Gazzanelli
Lancet (London, England)|May 31, 2001
Prostate cancer screeningF Mannello, G Gazzanelli
International Angiology : a Journal of the International Union of Angiology|April 24, 2014
Pathophysiology of chronic venous diseaseJ D Raffetto, F Mannello
Lancet (London, England)|August 31, 1999
Breast cancer in women with palpable breast cystsF Mannello, M Malatesta, G Gazzanelli
Cancer|July 1, 1995
Breast cancer diagnosis by lactate dehydrogenase isozymes in nipple dischargeF Mannello, F Marcheggiani, G Gazzanelli
Current Cancer Drug Targets|June 25, 2005
Matrix metalloproteinase inhibitors as anticancer therapeuticsF Mannello, G Tonti, S Papa
Pageof 7